In November of 1993, the Dutch government recommended daily folic acid supplementation of 0.4 or 0.5 mg for all women planning pregnancy, starting 4 weeks before conception until 8 weeks after. In 1995, a onetime mass media campaign was conducted, and due to this campaign, the use of folic acid in this recommended period increased from 4. 8% in 19958% in to 21% in 19968% in . Subsequently, no structural strategies were undertaken until 2003, and at that time, 22% of lower-educated women used folic acid in the recommended period. The prevalence of neural tube defects (NTD) decreased from 11.44/10,000 before the official recommendations to 6.52/10,000 thereafter. Currently, community pharmacies proactively approach women before their first pregnancy on the subject of folic acid supplementation. This is done by means of a sticker placed on packages of oral contraceptives with the text "Child wish?*". Ask for information about folic acid in your pharmacy, "and a brochure (leaflet) containing detailed information about folic acid. (*"Child wish" refers to women who plan to become pregnant.) Data from an explorative, comparative study strongly suggest that this intervention is effective. Sustainable education programs through which women are informed repeatedly to take folic acid supplements during the periconceptional period are urgently needed.
Introduction
In the early 1990s, it became clear that supplementation with folic acid taken by women during the periconceptional period substantially decreased the risk of neural tube defects (NTD) in their children [1, 2] . Public health authorities in many countries have since taken steps to improve the periconceptional intake of folic acid. The United States and some developing countries choose to fortify staple foods [3, 4] , but so far, most European countries (apart from Hungary and Ireland) have decided not to do so -although some specific fortified products are available in many European countries. Seven European countries, including the Netherlands, conduct official health education initiatives to promote the use of folic acid supplements. But despite the measures taken to date, the majority of women in all countries surveyed are not taking folic acid supplementation during the periconceptional period. This is reflected in the lack of a clear decline in the prevalence of NTD across Europe [5] .
The Dutch situation
In November of 1993, a Joint Committee of the Dutch Health Council and the Dutch Food Council recommended folic acid supplementation for all women planning pregnancy, as legislation did not allow for folic acid fortification. The Committee discerned three types of groups [6] : 1) women with a prior NTD pregnancy (recurrence group), who were advised to take 4 or 5 mg of folic acid per day starting 4 weeks before conception until 8 weeks after conception; 2) women with a higher risk due to other risk factors (such as positive family history for NTD, the use of antiepileptics, diabetes mellitus, and the use of ovulation-inducing drugs), who were advised to take 0.4 or 0.5 mg of folic acid daily starting 4 weeks before conception until 8 weeks after conception; and 3) women with a normal population risk who were also advised to take 0.4 or 0.5 mg of folic acid daily starting 4 weeks before conception until 8 weeks after conception. This advice was adopted by the Chief Inspector of Health, who informed all health care professionals in a letter stating that all women planning a pregnancy were to be advised to take a 0.5 mg folic acid tablet supplement daily [7] . However, the main problem with folic acid supplementation with tablets is that is sometimes difficult to reach the target group in time. Furthermore, since periconceptional counseling is not very common in the Netherlands, it is also difficult for general practitioners and midwives to inform women about the benefits of folic acid in time. Therefore, community pharmacists play an important role in communicating this health measure to the target group through information provided by stickers placed on box labels of oral contraceptives.
National Folic Acid Campaign
To stimulate the implementation of the folic acid supplementation recommendation, the Ministry of Health, Welfare and Sports, in cooperation with the Dutch Nutrition and Food Bureau (VoVo), the Dutch Alliance of Parent and Patient Organizations of genetic and nongenetic congenital disorders (VSOP), and the National Organization for Municipal Health Services, initiated a national public health promotion campaign. This national folic acid campaign involved a two-step strategy: one aiming at health care professionals and the second at women planning pregnancy. This campaign started in the beginning of 1995, first focusing on health care professionals, e.g., general practitioners, midwives, obstetricians, and pharmacists. They were informed about folic acid through their professional associations, publications in national medical journals, and personal correspondence, before the campaign was implemented. In this way, health care professionals were provided with educational materials on advising women about the use of folic acid. A special brochure was sent addressing the many questions about folic acid that women could have.
A survey among general practitioners in 1996 showed that 87% were familiar with the folic acid campaign and about 50% considered the use of folic acid by women planning pregnancy as important. Two-thirds thought that it could contribute to medicalization of the pregnancy. Most general practitioners (82%) thought that pregnant women who had not used folic acid might develop feelings of guilt. Nevertheless, 64% of general practitioners in the survey recommended folic acid supplementation and were willing to prescribe it to women who asked for it [8] .
In September of 1995, the campaign began to inform women of childbearing age about the benefits and use of folic acid. For this purpose, mass media methods were used. The slogan of the campaign was "Folic acid -before you are pregnant. " A variety of sources were used to draw the attention of women planning pregnancy to a brochure about folic acid. These sources included advertisements in newspapers and women's magazines, television and radio commercials, and posters in the waiting rooms of general practitioners, midwives, and obstetricians. These brochures were also available at no cost in community pharmacies and imparted full information about NTD and recommendations on the perinatal use of folic acid. The aim was to inform at least 70% of women planning pregnancy, and to achieve proper folic acid use in 65% of women who had heard of it.
An additional local campaign was conducted in two regions in the south of the Netherlands (Midden Brabant and Achterhoek) to inform women of low socioeconomic status about folic acid. These women appear to be at greater risk of giving birth to a child with NTD and are generally more difficult to reach than women of high socioeconomic status. In these regions, intermediates (such as general practitioners, midwives, obstetricians, dietists, pharmacists, drug stores, migrant workers, etc.) received extra information about folic acid. Information was published in commercial newspapers and also conveyed on large billboards along the roads, advertisements at bus stops and on buses, local radio programs, in free newspapers, and at a special stand during a regional pregnancy information market.
Effect of the national folic acid campaign
Evaluation of the effects of the national and local folic acid campaigns included measuring the awareness and use of folic acid by pregnant women in four regions in the Netherlands, before (1995) and after (1996) the campaign. To this end, pregnant women who visited a midwife, general practitioner, or obstetrician for the first or second prenatal visit were asked to complete a questionnaire. In 1996, 77% had heard of folic acid before pregnancy, and the use of folic acid during any time around conception increased from 25.1% in 1995 to 53.5% in 1996. Use of folic acid in the entire recommended period (4 weeks before until 8 weeks after conception) increased from 4.8% in 1995 to 21.0% in 1996. Seventeen percent of women with low education (low socioeconomic status) and 32% of women with higher education (high socioeconomic status) used folic acid during the recommended period. No additional effect of the local folic acid campaign was found (adjusted OR = 1.0; 95% CI, 0.7 to 1.4). It was then possible to conclude that folic acid supplementation during the recommended period increased considerably as a result of the national and local folic acid campaigns, but the target use of folic acid in 46% of women wishing to conceive was not achieved [9, 10] . 
Monitoring folic acid use every 2 to 3 years
In the northern Netherlands, awareness and periconceptional use of folic acid among pregnant women is measured every 2 to 3 years. Women fill out a questionnaire during their first or second antenatal visit. The highest fulfilled level of education is taken as the primary indicator of socioeconomic status. In 2003, the general level of folic acid awareness was high, but with significant differences relating to socioeconomic status. A quarter of the lower-educated women did not know about folic acid before pregnancy (table l), and 20% of women of lower socioeconomic status knew the correct period of use, as compared with nearly 50% in the higher socioeconomic status group. The correct use of folic acid among the lower-educated women has decreased over the past 3 years (down to 22% in 2003), and increased for the higher socioeconomic status groups (up to 59% in 2003), implying larger differences in health ( fig. 1 ). We can conclude from the most recent survey that in 2003, 8 years after the mass media campaign, public awareness and use of folic acid increased considerably in comparison with the awareness estimated at the start of the campaign. However, differences in knowledge and use of folic acid with respect to level of education were quite significant that year. As a result, it can be argued that once-only campaigns of this nature have only short-term effects, especially for lower-educated women. Implementing strategies to promote daily folic acid use in structured health care programs are needed.
Prevalence of neural tube defects
In the northern Netherlands, there was a 43% (95% CI, 15% to 61%) reduction in the total prevalence of NTD from 11.44 per 10,000 in 1989-1991 to 6.52 per 10,000 in 2000-2002 [11] .
The project "ZorgVoor... Foliumzuur bij kinderwens" via community pharmacies
The objective of this project is to inform as many women as possible about taking supplemental folic acid before they try to become pregnant for the first time, through permanent health promotion interventions (ACTIVER method) via community pharmacies [12] . The ACTIVER method is a tailored variant of action research composed of two workshops of four to six pharmacies (each represented by a pharmacist and one or two assistants), observation and feedback using client questionnaires, and instruction and evaluation meetings in the pharmacy. Experienced pharmacists and project consultants coach the workshops. Each pharmacy is initially provided with at least 1,000 stickers and leaflets. Additional materials are available at no cost. The objective of the introduction program is to achieve a quality and lasting implementation of health promotion activities. The minimal health promotion interventions include informative stickers placed on boxes of oral contraceptives and distribution of 
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Folic acid supplementation in the Netherlands information leaflets, with instructions conveyed orally by the health care provider or in writing. Additional information is provided by window presentations, posters, websites, free publicity via local media, service magazines, etc. A total of 227 pharmacies (about 50% of the total) in the northern and eastern parts of the Netherlands participated in the project in 2004. Collected and processed data showed that 85% of all oral contraceptive users received a sticker on an oral contraceptive box, 63% received a leaflet (of whom 61% read the leaflet), and 93% approved the initiative of the community pharmacy. By 2005, about 450 pharmacies (40%) from all other parts of the Netherlands had subscribed to the project. The effectiveness of this initiative was measured in a controlled pilot study. The consumption of folic acid by women who were planning to become pregnant was 30% higher in the intervention group than in the control group [12] . A randomized controlled study (with pre-and post-measurements) to assess the magnitude of the effectiveness is currently in progress. Results will be available in the first half of 2006.
